The Institute of Nuclear Medicine and Allied Sciences (INMAS), a lab of Defence Research and Development Organisation (DRDO) has developed an anti-Covid-19 therapeutic application of the drug 2-deoxy-D-glucose (2-DG), in collaboration with Dr Reddy’s Laboratories, Hyderabad.
Clinical trial results have shown that this molecule helps in faster recovery of hospitalized patients and reduces supplemental oxygen dependence. Higher proportion of patients treated with 2-DG showed RT-PCR negative conversion in COVID patients. The drug will be of immense benefit to the people suffering from Covid-19 in the ongoing pandemic.
#DRDO #AntiCovidDrug #IndiaToday
Subscribe to India Today for NEW VIDEOS EVERY DAY and make sure to enable Push Notifications so you'll never miss a new video.
All you need to do is PRESS THE BELL ICON next to the Subscribe button!
India Today TV is India's leading English News Channel. India Today YouTube channel offers latest news videos on Politics, Business, Cricket, Bollywood, Lifestyle, Auto, Technology, Travel, Entertainment and a lot more.
Stay tuned for latest updates and in-depth analysis of news from India and around the world!
Follow us: Official website: [ Ссылка ]
Twitter: [ Ссылка ]
Facebook: [ Ссылка ]
Telegram: [ Ссылка ]
